News
Lululemon (LULU) Stock Sinks As Market Gains: Here's Why
In the latest close session, Lululemon (LULU) was down 2.64% at $195.19. The stock's change was less than the S&P 500's daily gain of 0.03%. Elsewhere, the Dow lost 0.03%, while the tech-heavy
Li Auto Inc. Sponsored ADR (LI) Stock Sinks As Market Gains: Here's Why
In the latest trading session, Li Auto Inc. Sponsored ADR (LI) closed at $23.75, marking a -4.62% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.03%
ZIM Integrated Shipping Services (ZIM) Stock Falls Amid Market Uptick: What Investors Need to Know
ZIM Integrated Shipping Services (ZIM) closed at $16.96 in the latest trading session, marking a -2.58% move from the prior day. The stock's change was less than the S&P 500's daily gain of 0.03%
Harmony Gold (HMY) Stock Sinks As Market Gains: What You Should Know
Harmony Gold (HMY) closed at $15.26 in the latest trading session, marking a -1.23% move from the prior day. This change lagged the S&P 500's 0.03% gain on the day. At the same time, the Dow lost
Macy's (M) Stock Sinks As Market Gains: Here's Why
In the latest close session, Macy's (M) was down 1.89% at $12.96. The stock trailed the S&P 500, which registered a daily gain of 0.03%. On the other hand, the Dow registered a loss of 0.03%, and
Carnival (CCL) Stock Dips While Market Gains: Key Facts
In the latest trading session, Carnival (CCL) closed at $30.25, marking a -1.27% move from the previous day. This move lagged the S&P 500's daily gain of 0.03%. Meanwhile, the Dow experienced a drop
Zscaler (ZS) Stock Sinks As Market Gains: Here's Why
Zscaler (ZS) ended the recent trading session at $270.99, demonstrating a -2.44% change from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.03%. Meanwhile, the Dow
Beam Global (BEEM) Reports Q2 Loss, Lags Revenue Estimates
Beam Global (BEEM) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.14 per share a year ago. These figures are
ESS Tech, Inc. (GWH) Reports Q2 Loss, Lags Revenue Estimates
ESS Tech, Inc. (GWH) came out with a quarterly loss of $0.9 per share versus the Zacks Consensus Estimate of a loss of $0.88. This compares to a loss of $1.8 per share a year ago. These figures are
Gambling.com Group Limited (GAMB) Q2 Earnings and Revenues Beat Estimates
Gambling.com Group Limited (GAMB) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.2 per share a year
Strattec Security (STRT) Beats Q4 Earnings and Revenue Estimates
Strattec Security (STRT) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $1.07 per share. This compares to earnings of $2.39 per share a year ago. These
Cibus (CBUS) Reports Q2 Loss, Lags Revenue Estimates
Cibus (CBUS) came out with a quarterly loss of $0.61 per share versus the Zacks Consensus Estimate of a loss of $0.69. This compares to a loss of $1.14 per share a year ago. These figures are
Dragonfly Energy Holdings Corp. (DFLI) Reports Q2 Loss, Tops Revenue Estimates
Dragonfly Energy Holdings Corp. (DFLI) came out with a quarterly loss of $0.58 per share versus the Zacks Consensus Estimate of a loss of $1.29. This compares to a loss of $1.98 per share a year
Deere’s Sell-Off Could Be a Long-Term Buying Chance
Deere & Co. (NYSE: DE) stock is dropping sharply after it lowered its full-year guidance, citing tariff uncertainty, cautious customer spending, and weaker crop prices. The stock was down more
Plus Therapeutics (PSTV) Reports Q2 Loss, Misses Revenue Estimates
Plus Therapeutics (PSTV) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to a loss of $0.71 per share a year ago. These
Compared to Estimates, Applied Materials (AMAT) Q3 Earnings: A Look at Key Metrics
Applied Materials (AMAT) reported $7.3 billion in revenue for the quarter ended July 2025, representing a year-over-year increase of 7.7%. EPS of $2.48 for the same period compares to $2.12 a year
Genasys (GNSS) Reports Q3 Loss, Beats Revenue Estimates
Genasys (GNSS) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.15 per share a year ago. These figures are
Bolt Biotherapeutics, Inc. (BOLT) Reports Q2 Loss, Tops Revenue Estimates
Bolt Biotherapeutics, Inc. (BOLT) came out with a quarterly loss of $4.46 per share versus the Zacks Consensus Estimate of a loss of $6.4. This compares to a loss of $11.2 per share a year ago
IGC Pharma, Inc. (IGC) Reports Q1 Loss, Misses Revenue Estimates
IGC Pharma, Inc. (IGC) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.03 per share a year ago. These figures
RenovoRx, Inc. (RNXT) Reports Q2 Loss, Tops Revenue Estimates
RenovoRx, Inc. (RNXT) came out with a quarterly loss of $0.08 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.1 per share a year ago. These figures are adjusted
Evolv Technologies Holdings, Inc. (EVLV) Reports Q2 Loss, Beats Revenue Estimates
Evolv Technologies Holdings, Inc. (EVLV) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to earnings of $0.02 per share a year
Profound Medical (PROF) Reports Q2 Loss, Misses Revenue Estimates
Profound Medical (PROF) came out with a quarterly loss of $0.52 per share versus the Zacks Consensus Estimate of a loss of $0.43. This compares to a loss of $0.28 per share a year ago. These figures
Guidance Watch: 2 Companies Bullishly Raising Forecasts
The 2025 Q2 earnings cycle is slowly winding down, which has been resilient so far.
For the 457 S&P 500 companies that have reported Q2 results as of August 13th, total earnings are up +11.6% from
P3 Health Partners Inc. (PIII) Reports Q2 Loss, Lags Revenue Estimates
P3 Health Partners Inc. (PIII) came out with a quarterly loss of $6.23 per share versus the Zacks Consensus Estimate of a loss of $3.29. This compares to a loss of $7.5 per share a year ago. These
MacroGenics (MGNX) Reports Q2 Loss, Tops Revenue Estimates
MacroGenics (MGNX) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to a loss of $0.89 per share a year ago. These figures are


